1.0Annual Reporthttps://www.ipsen.com/annualreportkonstantinoskampanoshttps://www.ipsen.com/annualreport/author/konstantinoskampanos/A conversation with David Loewrich600338<blockquote class="wp-embedded-content" data-secret="ajVDCNG0Ry"><a href="https://www.ipsen.com/annualreport/a-conversation-with-david-loew/">A conversation with David Loew</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.ipsen.com/annualreport/a-conversation-with-david-loew/embed/#?secret=ajVDCNG0Ry" width="600" height="338" title="“A conversation with David Loew” — Annual Report" data-secret="ajVDCNG0Ry" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.ipsen.com/annualreport/wp-includes/js/wp-embed.min.js
</script>
Using science with purpose to deliver for patients. In 2024, we continued to deliver against our strategy across all four pillars. We achieved strong results, brought multiple new medicines to patients, expanded our pipeline and continued to build a culture of impact.